Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yusuke Oshiro
Observed names:
Oshiro, Yusuke,
Y. Oshiro
Institutions:
National Center for Global Health and Medicine,
Japan Institute for Health Security
Observed institutions:
National Center for Global Health and Medicine,
Urasoe General Hospital,
Nakagami Hospital,
Center Hospital of National Center for Global Health and Medicine,
Japan Institute for Health Security
ORCID:
0000-0001-8125-6590
Observed ORCID:
0000-0001-8125-6590
OpenAlex ID:
A5033844568
Sex‐associated differences between BMI and SARS‐CoV‐2 antibody titers following the BNT162b2 vaccine
2022
·
Shohei Yamamoto
, Tetsuya Mizoue
, et al.
·
Obesity
·
68
PDF
Durability and determinants of anti-SARS-CoV-2 spike antibodies following the second and third doses of mRNA COVID-19 vaccine
2023
·
Shohei Yamamoto
, Yusuke Oshiro
, et al.
·
Clinical Microbiology and Infection
·
35
PDF
Seroprevalence of SARS-CoV-2 antibodies in a national hospital and affiliated facility after the second epidemic wave of Japan
2021
·
Shohei Yamamoto
, Akihito Tanaka
, et al.
·
Journal of Infection
·
16
PDF
Preinfection Neutralizing Antibodies, Omicron BA.5 Breakthrough Infection, and Long COVID: A Propensity Score-Matched Analysis
2023
·
Shohei Yamamoto
, Kouki Matsuda
, et al.
·
The Journal of Infectious Diseases
·
14
PDF
Sensitivity of anti-SARS-CoV-2 nucleocapsid protein antibody for breakthrough infections during the epidemic of the Omicron variants
2022
·
Tetsuya Mizoue
, Shohei Yamamoto
, et al.
·
Journal of Infection
·
14
PDF
Interferon lambda 3 in the early phase of coronavirus disease‐19 can predict oxygen requirement
2022
·
Tetsuya Suzuki
, Noriko Iwamoto
, et al.
·
European Journal of Clinical Investigation
·
12
PDF
Neutralizing antibodies after three doses of the BNT162b2 vaccine, breakthrough infection, and symptoms during the Omicron-predominant wave
2023
·
Shohei Yamamoto
, Kouki Matsuda
, et al.
·
International Journal of Infectious Diseases
·
11
Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants
2023
·
Tetsuya Mizoue
, Shohei Yamamoto
, et al.
·
Epidemiology and Infection
·
10
PDF
Comparison of risk factors for SARS-CoV-2 infection among healthcare workers during Omicron and Delta dominance periods in Japan
2023
·
Y. Li
, S. Yamamoto
, et al.
·
Journal of Hospital Infection
·
10
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
2023
·
Shohei Yamamoto
, Kouki Matsuda
, et al.
·
BMC Infectious Diseases
·
9
PDF
Vitamin D deficiency during the coronavirus disease 2019 (COVID-19) pandemic among healthcare workers
2024
·
Aoi Ito
, Shohei Yamamoto
, et al.
·
Clinical Nutrition ESPEN
·
8
PDF
Clostridium ramosum bacteremia: A case series at a general acute care hospital
2022
·
Takashi Shinzato
, Tadahiro Yonaha
, et al.
·
Journal of Infection and Chemotherapy
·
8
Correlates of Nucleocapsid Antibodies and a Combination of Spike and Nucleocapsid Antibodies Against Protection of SARS-CoV-2 Infection During the Omicron XBB.1.16/EG.5–Predominant Wave
2024
·
Shohei Yamamoto
, Yusuke Oshiro
, et al.
·
Open Forum Infectious Diseases
·
7
PDF
Dyslipidemia and SARS‐CoV‐2 spike antibody titres after the second and third doses of the BNT162b2 vaccine among healthcare workers in Japan
2022
·
Zobida Islam
, Shohei Yamamoto
, et al.
·
Diabetes/Metabolism Research and Reviews
·
7
Inpatient antibiotic prescribing patterns using the World Health Organization (WHO) Access Watch and Reserve (AWaRe) classification in Okinawa, Japan: A point-prevalence survey
2022
·
Payal K. Patel
, Naoyuki Satoh
, et al.
·
Antimicrobial Stewardship & Healthcare Epidemiology
·
6
PDF
High diagnostic accuracy of quantitative SARS-CoV-2 spike-binding-IgG assay and correlation with in vitro viral neutralizing activity
2024
·
Noriko Iwamoto
, Yuki Takamatsu
, et al.
·
Heliyon
·
5
Kinetics and durability of nucleocapsid-specific antibodies after SARS-CoV-2 reinfection
2023
·
Shohei Yamamoto
, Tetsuya Mizoue
, et al.
·
Journal of Infection
·
5
Association of Impaired Fasting Glucose and Diabetes with SARS-CoV-2 Spike Antibody Titers after the BNT162b2 Vaccine among Health Care Workers in a Tertiary Hospital in Japan
2022
·
Zobida Islam
, Shohei Yamamoto
, et al.
·
Vaccines
·
5
PDF
Antibody responses and correlates after two and three doses of BNT162b2 COVID-19 vaccine
2022
·
Shohei Yamamoto
, Akihito Tanaka
, et al.
·
Infection
·
4
PDF
Sensitivity of three antibody assays to SARS-CoV-2 nucleocapsid protein in relation to timing since diagnosis
2021
·
Tetsuya Mizoue
, Shohei Yamamoto
, et al.
·
GHM Open
·
4
PDF
Consistency of the results of rapid serological tests for SARS-CoV-2 among healthcare workers in a large national hospital in Tokyo, Japan
2021
·
Shohei Yamamoto
, Akihito Tanaka
, et al.
·
Global Health & Medicine
·
4
PDF
Protection of Omicron Bivalent Vaccine, Previous Infection, and Their Induced Neutralizing Antibodies Against Symptomatic Infection With Omicron XBB.1.16 and EG.5.1
2024
·
Shohei Yamamoto
, Kouki Matsuda
, et al.
·
Open Forum Infectious Diseases
·
3
COVID-19 severity and corticosteroid treatment have minimal effect on specific antibody production
2024
·
Takato Nakamoto
, Noriko Iwamoto
, et al.
·
BMC Infectious Diseases
·
2
PDF
Trends of participants in convalescent plasma donation for COVID-19 in Japan as the pandemic evolved
2023
·
Tetsuya Suzuki
, Yusuke Asai
, et al.
·
Heliyon
·
2
Serum vitamin D and the risk of SARS-CoV-2 and seasonal influenza infection during the twindemic period
2025
·
Aoi Ito
, Shohei Yamamoto
, et al.
·
Clinical Nutrition ESPEN
·
1
Show more works
View as search
Works count:
35
Citation count:
270
H-index:
9
I10-index:
9
Year
Topic
Type